Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Auriault

Showing results (111-120 of 120) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 120 results.
Molecular Immunology|November 1, 1992
Determination of B-cell epitopes of nef HIV-I protein: immunogenicity related to their structureJ Estaquier, C Boutillon, J C Ameisen, et al.
Molecular Immunology|April 1, 1992
T helper cell epitopes of the human immunodeficiency virus (HIV-1) nef protein in rats and chimpanzeesJ Estaquier, C Boutillon, J C Ameisen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 15, 1991
Antigenicity and immunogenicity of a multiple peptidic construction of the Schistosoma mansoni Sm-28 GST antigen in rat, mouse, and monkey. 1. Partial protection of Fischer rat after active immunizationI Wolowczuk, C Auriault, M Bossus, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 21, 1998
Dermal endothelial cells and keratinocytes produce IL-7 in vivo after human Schistosoma mansoni percutaneous infectionO Roye, N Delhem, F Trottein, et al.
Memorias Do Instituto Oswaldo Cruz|January 1, 1987
GP38, P28-I and P28-II: candidates for a vaccine against schistosomiasisR J Pierce, J M Balloul, J M Grzych, et al.
Annales De Biologie Clinique|January 1, 1989
[Antigens of Toxoplasma gondii with a diagnostic and potential immunoprophylactic value: new strategies of identification]F Darcy, G Torpier, M F Cesbron-Delauw, et al.
Journal of Clinical Microbiology|September 1, 1990
Antibody response of Schistosoma mansoni-infected human subjects to the recombinant P28 glutathione-S-transferase and to synthetic peptidesC Auriault, H Gras-Masse, R J Pierce, et al.
The Journal of Infectious Diseases|May 24, 2000
Sex-dependent neutralizing humoral response to Schistosoma mansoni 28GST antigen in infected human populationsF Remoué, F Rogerie, M C Gallissot, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 24, 2009
Increased expression of regulatory Tr1 cells in recurrent hepatitis C after liver transplantationA Carpentier, F Conti, F Stenard, et al.
Tropical Medicine & International Health : TM & IH|September 28, 1999
Cellular immune responses of a Senegalese community recently exposed to Schistosoma mansoni: correlations of infection level with age and inflammatory cytokine production by soluble egg antigen-specific cellsM Marguerite, M C Gallissot, M Diagne, et al.
Pageof 12

Showing results (111-120 of 120) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 120 results.
Molecular Immunology|November 1, 1992
Determination of B-cell epitopes of nef HIV-I protein: immunogenicity related to their structureJ Estaquier, C Boutillon, J C Ameisen, et al.
Molecular Immunology|April 1, 1992
T helper cell epitopes of the human immunodeficiency virus (HIV-1) nef protein in rats and chimpanzeesJ Estaquier, C Boutillon, J C Ameisen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 15, 1991
Antigenicity and immunogenicity of a multiple peptidic construction of the Schistosoma mansoni Sm-28 GST antigen in rat, mouse, and monkey. 1. Partial protection of Fischer rat after active immunizationI Wolowczuk, C Auriault, M Bossus, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 21, 1998
Dermal endothelial cells and keratinocytes produce IL-7 in vivo after human Schistosoma mansoni percutaneous infectionO Roye, N Delhem, F Trottein, et al.
Memorias Do Instituto Oswaldo Cruz|January 1, 1987
GP38, P28-I and P28-II: candidates for a vaccine against schistosomiasisR J Pierce, J M Balloul, J M Grzych, et al.
Annales De Biologie Clinique|January 1, 1989
[Antigens of Toxoplasma gondii with a diagnostic and potential immunoprophylactic value: new strategies of identification]F Darcy, G Torpier, M F Cesbron-Delauw, et al.
Journal of Clinical Microbiology|September 1, 1990
Antibody response of Schistosoma mansoni-infected human subjects to the recombinant P28 glutathione-S-transferase and to synthetic peptidesC Auriault, H Gras-Masse, R J Pierce, et al.
The Journal of Infectious Diseases|May 24, 2000
Sex-dependent neutralizing humoral response to Schistosoma mansoni 28GST antigen in infected human populationsF Remoué, F Rogerie, M C Gallissot, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 24, 2009
Increased expression of regulatory Tr1 cells in recurrent hepatitis C after liver transplantationA Carpentier, F Conti, F Stenard, et al.
Tropical Medicine & International Health : TM & IH|September 28, 1999
Cellular immune responses of a Senegalese community recently exposed to Schistosoma mansoni: correlations of infection level with age and inflammatory cytokine production by soluble egg antigen-specific cellsM Marguerite, M C Gallissot, M Diagne, et al.
Pageof 12